5 active not recruiting, 4 completed, 3 unknown, 2 recruiting. 14 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 14 | Active not recruiting 5, Completed 4, Unknown 3, Recruiting 2 |
Follow HPV Infection: new trials by email Literature Review of HPV Infection trials Research Report on HPV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years bivalent HPV vaccine, 9-valent HPV vaccine - HPV Infection | Phase 4 | Active not recruiting | Zhejiang Provincial Center for Disease Control and Prevention | 400 | 2025-12-20 | 2026-06-11 |
| Treatment of HPV Infection in Perimenopausal and Postmenopausal Women Human interferon alpha 2b vaginal Effervescent capsules - HPV Infection | Phase 4 | Unknown | Qianfoshan Hospital | 150 | 2023-07-01 | 2023-05-18 |
| Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) 9-valent HPV vaccine, 2 doses alternate timing, 9-valent HPV vaccine, 3 doses standard timing - Immunization, HPV Infection | Phase 4 | Active not recruiting | The University of Texas Medical Branch, Galveston | 618 | 2023-01-18 | 2026-11-06 |
| HPV Vaccine Immunity in High-risk Women Gardasil®, Merck - HPV Infection | Phase 4 | Completed | Murdoch Childrens Research Institute | 63 | 2022-09-14 | 2024-02-01 |
| Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania Gardasil® HPV vaccine - HPV Infection, Vaccine Preventable Disease | Phase 4 | Recruiting | London School of Hygiene and Tropical Medicine | 10400 | 2022-08-01 | 2026-09-08 |
| Immunogenicity of Fractional Dose of the HPV Vaccines HPV vaccine - HPV Infection, HPV Vaccine | Phase 4 | Active not recruiting | University of Washington | 92 | 2022-06-15 | 2026-05-05 |
| Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine - HPV Infection, HPV Vaccination | Phase 4 | Completed | University of Washington | 158 | 2022-05-25 | 2023-11-29 |
| HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini Gardasil ® 9 - HPV Infection, Hiv | Phase 4 | Completed | Columbia University | 1403 | 2022-03-31 | 2026-10-27 |
| "Lactobacillus Crispatus M247, LSIL and Microbiota" Lactobacillus Crispatus M247 - Vaginal Flora Imbalance, ASC-US | Phase 4 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 90 | 2021-06-16 | 2023-04-11 |
| Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden Gardasil9 - HPV Infection, CIN 2/3 | Phase 4 | Recruiting | Miriam Elfström | 150000 | 2021-05-03 | 2021-09-16 |
| An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen Gardasil 9 2 dose regimen, Gardasil 9 3 dose regimen, Gardasil 9 rescue dose - HPV Infection | Phase 4 | Active not recruiting | Boston Medical Center | 352 | 2020-12-01 | 2026-11-05 |
| Intradermal, Fractional Dose of HPV Vaccines: HPV vaccine - HPV Infection, HPV Vaccine | Phase 4 | Active not recruiting | University of Washington | 40 | 2020-11-01 | 2026-05-05 |
| Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women Human Papillomavirus 9-valent Vaccine, Recombinant - HIV Infections, HPV Infection | Phase 4 | Unknown | University Hospital Virgen de las Nieves | 158 | 2020-02-12 | 2024-07-10 |
| Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection Monogin - HPV Infection | Phase 4 | Completed | AGUNCO Obstetrics and Gynecology Centre | 2012-04-19 |
Papillomavirus Infections (14) · Acquired Immunodeficiency Syndrome (1) · Atypical Squamous Cells of the Cervix (1) · HIV Infections (1) · Uterine Cervical Neoplasms (1) · Vaccine-Preventable Diseases (1)
Communicable Diseases (14) · DNA Virus Infections (14) · Disease Attributes (14) · Genital Diseases (14) · Infections (14) · Pathologic Processes (14) · Pathological Conditions, Signs and Symptoms (14) · Sexually Transmitted Diseases (14) · Sexually Transmitted Diseases, Viral (14) · Tumor Virus Infections (14) · Urogenital Diseases (14) · Virus Diseases (14) · Blood-Borne Infections (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2)
Human Papillomavirus Recombinant Vaccine nonavalent (3) · Papillomavirus Vaccines (2) · Clinical Protocols (1) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1) · Vaccines, Synthetic (1) · human papillomavirus vaccine, L1 type 16, 18 (1)
University of Washington (3) · AGUNCO Obstetrics and Gynecology Centre (1) · Boston Medical Center (1) · Columbia University (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · London School of Hygiene and Tropical Medicine (1) · Miriam Elfström (1) · Murdoch Childrens Research Institute (1) · Qianfoshan Hospital (1) · The University of Texas Medical Branch, Galveston (1) · University Hospital Virgen de las Nieves (1) · Zhejiang Provincial Center for Disease Control and Prevention (1)
United States (4) · Italy (2) · China (1) · Eswatini (1) · Kenya (1) · Spain (1) · Sweden (1) · Tanzania (1) · Vietnam (1)
Abbey B Berenson, MD, PhD (1) · Anna Wald, MD (1) · Carl G Streed, MD MPH (1) · Elaine Abrams, MD (1) · Helen Stankiewicz Karita, MD (1) · Joakim Dillner, MD, PhD (1) · Kim Mulholland, MBBS (1) · Nelly Mugo, MD (1) · Shenyu Wang (1) · Xolisile Dlamini (1)
PMID 41276263, PMID 23009652, PMID 38693149, PMID 41764658, PMID 42142523